These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 24280908

  • 1. Degree of decrease in central retinal thickness predicts visual acuity response to intravitreal ranibizumab in diabetic macular edema.
    Santos AR, Gomes SC, Figueira J, Nunes S, Lobo CL, Cunha-Vaz JG.
    Ophthalmologica; 2014; 231(1):16-22. PubMed ID: 24280908
    [Abstract] [Full Text] [Related]

  • 2. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L, Cserhati S, Seidensticker F, Liegl R, Kampik A, Ulbig M, Neubauer AS, Kernt M.
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [Abstract] [Full Text] [Related]

  • 3. Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.
    Pearce I, Banerjee S, Burton BJ, Chakravarthy U, Downey L, Gale RP, Gibson J, Pagliarini S, Patel J, Sivaprasad S, Andrews C, Brittain C, Warburton J, RELIGHT Study Group.
    Ophthalmology; 2015 Sep; 122(9):1811-9. PubMed ID: 26150052
    [Abstract] [Full Text] [Related]

  • 4. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
    Ozturk BT, Kerimoglu H, Bozkurt B, Okudan S.
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
    [Abstract] [Full Text] [Related]

  • 5. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
    Retina; 2006 Aug; 26(9):999-1005. PubMed ID: 17151486
    [Abstract] [Full Text] [Related]

  • 6. Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema.
    Kim M, Lee P, Kim Y, Yu SY, Kwak HW.
    Ophthalmologica; 2011 Aug; 226(3):138-44. PubMed ID: 21822008
    [Abstract] [Full Text] [Related]

  • 7. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.
    Pieramici DJ, Wang PW, Ding B, Gune S.
    Ophthalmology; 2016 Jun; 123(6):1345-50. PubMed ID: 26992841
    [Abstract] [Full Text] [Related]

  • 13. Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.
    Sophie R, Lu N, Campochiaro PA.
    Ophthalmology; 2015 Jul; 122(7):1395-401. PubMed ID: 25870079
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.
    Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME, Pan-American Collaborative Retina Study Group.
    Ophthalmology; 2007 Apr; 114(4):743-50. PubMed ID: 17398322
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
    Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS, RISE and RIDE Research Group.
    Ophthalmology; 2012 Apr; 119(4):789-801. PubMed ID: 22330964
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Short-term fluctuation of diabetic macular edema after intravitreal ranibizumab injection.
    Querques G, Bux AV, Martinelli D, Iaculli C, Del Curatolo MV, Delle Noci N.
    Retina; 2009 Oct; 29(9):1274-81. PubMed ID: 19696699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.